Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Altundag

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?O Dizdar, S Aksoy, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
Bone morphogenetic proteins and zoledronic acidU Sahin, A Alkan, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?I Sahin, E Ararat, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2009
Bone morphogenetic proteins and zoledronic acidU Sahin, A Alkan, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
Vemurafenib-induced hypertension: is it real?O Balakan, T Babacan, K Altundag
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 30, 2009
Synchronous ovarian cancer in a patient with pleomorphic lobular breast cancer: a therapeutic dilemmaO Dizdar, C Arslan, K Altundag
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 16, 2009
Triple-negative breast cancer and brain metastasesB Sait, E Cinar, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 29, 2012
Promising therapeutic options in triple-negative breast cancerA Bilici, C Arslan, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Late local recurrences in a randomized trial comparing conservative treatment with total mastectomy in early breast cancer patients: the impact of receptor status on local relapseO Altundag, K Altundag, M Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2008
Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?O Dizdar, S Aksoy, K Altundag
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?O Dizdar, S Aksoy, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
Bone morphogenetic proteins and zoledronic acidU Sahin, A Alkan, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?I Sahin, E Ararat, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2009
Bone morphogenetic proteins and zoledronic acidU Sahin, A Alkan, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
Vemurafenib-induced hypertension: is it real?O Balakan, T Babacan, K Altundag
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 30, 2009
Synchronous ovarian cancer in a patient with pleomorphic lobular breast cancer: a therapeutic dilemmaO Dizdar, C Arslan, K Altundag
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 16, 2009
Triple-negative breast cancer and brain metastasesB Sait, E Cinar, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 29, 2012
Promising therapeutic options in triple-negative breast cancerA Bilici, C Arslan, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Late local recurrences in a randomized trial comparing conservative treatment with total mastectomy in early breast cancer patients: the impact of receptor status on local relapseO Altundag, K Altundag, M Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2008
Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?O Dizdar, S Aksoy, K Altundag
Pageof 9